Destination XL Group

DXLG · NASDAQ

$0.4559−$0.0361 (−7.34%)TodayMarket closed · Oct 20, 4:00 PM ET

Prev close $0.492

DXLG analyst rating

BuyConsensus of 1 analyst over the last 12 months. 100% rate it a buy.

Strong buy0
Buy1
Hold0
Underperform0
Sell0

12-month price target · 3 analysts

Average $1.27 (+179.7% upside)

Low: $1.26
Now: $0.4559
High: $1.31

Upgrades and downgrades

The latest rating actions, newest first

DXLG analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
DA Davidson	Sep 11, 2026	Maintains	Buy	$1.50 → $1.25	62%
DA Davidson	Jun 4, 2026	Maintains	Buy	$1.50	62%
DA Davidson	May 13, 2026	Maintains	Buy	$1.50	62%
DA Davidson	Mar 20, 2026	Maintains	Buy	$2.00 → $1.50	62%

The case for and against

Updated Oct 16, 2026

Bull case

Destination XL Group is supported by improving merchandise margins, as it has offset supply-chain-related cost pressures through lower markdowns and reduced promotions while maintaining a strong product mix and customer service edge in the big-and-tall niche. Its FitMAP program is gaining traction, with 100,000 customers engaged since inception and deployment in 188 of 293 stores, suggesting higher basket sizes, better order values, and stronger repeat shopping behavior. Management’s push toward hybrid casualwear, less than 5% merchandise sourced from China, and the potential long-term benefit from GLP-1-driven wardrobe refresh demand all reinforce a constructive fundamental outlook despite inflation and competitive risks.

Bear case

Destination XL Group is facing a weakening sales backdrop as comp declines, though smaller than in prior periods, still decelerated through 1Q26, with February down 1.3%, March down 2.7%, and April down 6.8% amid inflation and rising gas prices. Gross margin also eroded by 80 bps to 44.3% from tariffs and heavier clearance, driving EBITDA to a $0.7M loss versus a $0.2M profit last year even as inventory was reduced 4.8% and receipts were slowed. While cash of $16.2M and no debt provide some cushion, free cash flow was a $12.7M use in 1Q26, and uncertainty around the $0.82 tender offer and reconsidered FullBeauty merger adds to the negative fundamental outlook.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.